Accrued expenses at September 30, 2019 and December 31, 2018 consist of the following:
September 30,
2019
December 31,
(unaudited)
2018
Payroll and Benefits
$
507,256
722,178
Clinical Trials
298,290
212,540
Professional Fees
172,396
165,894
Consulting
4,653
9,401
Short-Term Portion of Capital Financing Obligation
—
4,715
Total Accrued Expenses
982,595
1,114,728
No definition available.
Tabular disclosure of the components of accrued liabilities.